Purpose: Understanding of the regulators of superficial zone protein (SZP)/lubricin synthesis is important for investigating disease, homeostasis of articular joint, and tissue engineering of functional superficial zone of articular cartilage. However, regulation of SZP synthesis by growth factors has not been systematically investigated. The aim of this study is to investigate the role of the TGF-β/BMP superfamily members on SZP synthesis in superficial zone chondrocytes and synoviocytes. Methods: Bovine calf stifle joints were used in this study. The superficial zone of articular cartilage was harvested using a dermatome. Synovium was also harvested, and the tissues were digested with 0.2% collagenase P. Isolated cells were plated in monolayer and cultured in the serum-free chemically defined media with or without growth factors. Supernatants of culture media were harvested and the SZP synthesis was analyzed by SDS-PAGE and Western blotting. SZP accumulation was also quantified by ELISA using purified SZP as standard. Whole cell lysates were used as samples for SDS-PAGE and Western blotting of TGF-β signaling molecules. Results: TGF-β possessed a robust capacity to stimulate SZP synthesis. We found that the three isoforms of TGF-β (TGF-β1, β2, and β3) exhibited a similar profile of action. The responses of superficial zone chondrocytes and synoviocytes to TGF-β demonstrated a similar manner. Very low dose, 0.01 ng/ml of TGF-β still had a capacity to up-regulate SZP synthesis. However, interestingly the dose-dependency of TGF-β in SZP synthesis was biphasic. High dose of TGF-β (30 ng/ml) was less effective than 1 to 10 ng/ml of TGF-β. To answer why high dose of TGF-β is less effective, we investigated the Smad pathway. The duration of phosphorylation of Smad 2 was shorter in a high dose of TGF-β (30 ng/ml) compared to a low dose (1 ng/ml), and this may explain the less effectiveness of high dose of TGF-β. The expression of inhibitory Smads, Smad 6 and Smad 7 were not up-regulated in a high dose of TGF-β (30 ng/ml) compared to a low dose (1 ng/ml). The up-regulation of SZP synthesis by TGF-β was completely abolished by SB-431542, an inhibitor of TGF-β type I receptor kinase. Moreover, SB-431542 decreased the basal level of SZP accumulation, suggesting that SB-431542 blocked not only the exogenous TGF-β signaling but also the endogenous TGF-β signaling. The same trend was observed both in superficial zone chondrocytes and synoviocytes. BMP-2, 4, and 7 up-regulated the SZP synthesis in a dosedependent manner. The effects of three BMPs demonstrated a similar manner. Interestingly the response of synoviocytes to BMPs was stronger compared to superficial zone chondrocytes. CDMP-1 exhibited no obvious effect in superficial zone chondrocytes. In contrast, CDMP-1 up-regulated SZP synthesis in a dose-dependent manner in synoviocytes. The concurrent treatment of TGF-β and BMPs exhibited a higer expression of SZP compared to the treatments of each alone. The synergism between TGF-β and BMPs was more apparent in synoviocytes compared to superficial zone chondrocytes. Similarly to CDMP-1, the responses to Activins were different between superficial zone chondrocytes and synoviocytes. Activin A, B, and AB demonstrated no obvious effects in superficial zone chondrocytes. In contrast, Activins up-regulated SZP synthesis in synoviocytes. Conclusions: TGF-β is an important regulator of SZP synthesis. There is a synergism between TGF-β and BMP. Synoviocytes are more sensitive to BMPs, CDMP, and Activins compared to superficial zone chondrocytes. SZP synthesis is differentially regulated in superficial zone chondrocytes and synoviocytes by the TGF-β/BMP superfamily members.
